Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • FDA approves first-of-kind device to treat obesity

  • Many religious people view science favorably, but reject certain scientific theories

  • Privacy challenges: Just four vague pieces of info can identify you, and your credit card

  • Is this the year you join the top one percent? Affluence more fluid than once thought

  • Infants create new knowledge while sleeping

  • Common pesticide may increase risk of ADHD

  • Walking on ice takes more than brains: 'Mini-brain' in spinal cord aids in balance

  • Texting may be more suitable than apps in treatment of mental illness

  • New clues about a brain protein with high affinity for valium

  • Public and scientists express strikingly different views about science-related issues

  •